Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0001181431-13-045385

Options or other derivatives

  • Executive Chairman acquired 54,570.24 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
ODONNELL FRANCIS E JR Executive Chairman 2013-08-13 Grant or award · Series A Convertible Preferred Stock +9,520.04 9,520.04 I
ODONNELL FRANCIS E JR Executive Chairman 2013-08-13 Grant or award · Series A Convertible Preferred Stock +45,050.2 45,050.2 I
Loading xslF345X03/rrd388591.xml…